What is SRZN's health score?

As of October 31, 2026, TradeApes rates Surrozen, Inc./DE (SRZN) 23 out of 100 (Stressed); valuation verdict: Inconclusive. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is SRZN's estimated fair value?

Our methods couldn't reach a reliable fair value for SRZN yet. This is a model assessment, not a price target or investment recommendation.

Is SRZN undervalued or overvalued?

Our model currently rates SRZN as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

📱 Now on iPhone — live scores, valuations & alerts on the go

Download iPhone App

Surrozen, Inc./DE (SRZN)

Name: TradeApes health score and valuation for Surrozen, Inc./DE (SRZN)
Creator: TradeApes
License: https://www.tradeapes.com/terms.html

Healthcare Inconclusive inconclusive stressed

$29.04

Updated: 2026-10-31

As of October 31, 2026, TradeApes rates Surrozen, Inc./DE (SRZN) 23 out of 100 (Stressed); valuation verdict: Inconclusive.

TradeApes Score

Financial Strength

39 Weak

Operating Trend

1 Stressed

Relative Value

9 Overvalued

Capital Allocation

11 Stressed

Risk Management

47 Mixed

Our methods couldn't reach a reliable fair value for SRZN yet.

Key Findings

What's working

+ Current and quick ratios average 12× — ample liquidity
+ Accruals are -262% of assets — earnings backed by cash
+ Beta 0.93 — moves less than the market

What to watch

− Operating margin contracted 334.1 points over about three years — eroding profitability
− Free-cash-flow margin -449% — burning cash
− Margins compressing 334.1 points — costs outpacing sales

See every signal behind SRZN's score →

AI-written analysis

The full Surrozen, Inc./DE (SRZN) analysis

Why the model reads SRZN as inconclusive, the methods that voted, and what would change the verdict. Written from the same filings as the score above. How these are written

Industry Related Stocks

Acumen Pharmaceuticals, Inc. (ABOS) Abpro Holdings, Inc. (ABPO) Abpro Holdings, Inc. (ABPWW) Arcellx, Inc. (ACLX) Alpha Cognition Inc. (ACOG) ADMA BIOLOGICS, INC. (ADMA)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.